Morgan Stanley’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-1
Closed -$2 7871
2022
Q4
$2 Sell
1
-869
-100% -$1.74K ﹤0.01% 7868
2022
Q3
$2K Buy
+870
New +$2K ﹤0.01% 7507
2022
Q2
Sell
-2
Closed 8089
2022
Q1
$0 Sell
2
-1
-33% ﹤0.01% 8215
2021
Q4
$0 Sell
3
-1,626
-100% ﹤0.01% 8190
2021
Q3
$53K Hold
1,629
﹤0.01% 6698
2021
Q2
$70K Sell
1,629
-47
-3% -$2.02K ﹤0.01% 6514
2021
Q1
$82K Buy
1,676
+984
+142% +$48.1K ﹤0.01% 6116
2020
Q4
$25K Buy
692
+646
+1,404% +$23.3K ﹤0.01% 6371
2020
Q3
$2K Sell
46
-1
-2% -$43 ﹤0.01% 6605
2020
Q2
$2K Hold
47
﹤0.01% 6475
2020
Q1
$2K Buy
47
+15
+47% +$638 ﹤0.01% 6417
2019
Q4
$2K Sell
32
-4
-11% -$250 ﹤0.01% 6520
2019
Q3
$7K Sell
36
-14
-28% -$2.72K ﹤0.01% 6307
2019
Q2
$13K Buy
50
+4
+9% +$1.04K ﹤0.01% 6063
2019
Q1
$17K Buy
46
+42
+1,050% +$15.5K ﹤0.01% 6061
2018
Q4
$1K Hold
4
﹤0.01% 6539
2018
Q3
$1K Sell
4
-1
-20% -$250 ﹤0.01% 6668
2018
Q2
$2K Sell
5
-10
-67% -$4K ﹤0.01% 6566
2018
Q1
$7K Buy
15
+7
+88% +$3.27K ﹤0.01% 6345
2017
Q4
$4K Buy
8
+6
+300% +$3K ﹤0.01% 6370
2017
Q3
$1K Sell
2
-1
-33% -$500 ﹤0.01% 6481
2017
Q2
$3K Buy
+3
New +$3K ﹤0.01% 6426
2017
Q1
Hold
0
6634
2016
Q4
Sell
-2
Closed -$1K 6585
2016
Q3
$1K Buy
2
+1
+100% +$500 ﹤0.01% 6450
2016
Q2
$1K Hold
1
﹤0.01% 6457
2016
Q1
$1K Hold
1
﹤0.01% 6494
2015
Q4
$1K Sell
1
-60
-98% -$60K ﹤0.01% 6586
2015
Q3
$88K Sell
61
-25
-29% -$36.1K ﹤0.01% 5475
2015
Q2
$191K Buy
86
+84
+4,200% +$187K ﹤0.01% 5269
2015
Q1
$6K Buy
2
+1
+100% +$3K ﹤0.01% 6314
2014
Q4
$4K Hold
1
﹤0.01% 6373
2014
Q3
$4K Sell
1
-53
-98% -$212K ﹤0.01% 6369
2014
Q2
$210K Buy
54
+44
+440% +$171K ﹤0.01% 5129
2014
Q1
$39K Sell
10
-55
-85% -$215K ﹤0.01% 5799
2013
Q4
$240K Buy
65
+19
+41% +$70.2K ﹤0.01% 4936
2013
Q3
$179K Buy
46
+21
+84% +$81.7K ﹤0.01% 4930
2013
Q2
$242K Buy
+25
New +$242K ﹤0.01% 4728